Literature DB >> 20308678

CSF markers in amyotrophic lateral sclerosis: has the time come?

Merit E Cudkowicz, Michael Swash.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20308678     DOI： 10.1212/WNL.0b013e3181d72c31

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  3 in total

1.  Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.

Authors:  Yuting Ren; Wenjia Zhu; Fang Cui; Fei Yang; Zhaohui Chen; Li Ling; Xusheng Huang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 2.  New developments and future opportunities in biomarkers for amyotrophic lateral sclerosis.

Authors:  Xueping Chen; Hui-Fang Shang
Journal:  Transl Neurodegener       Date:  2015-09-30       Impact factor: 8.014

Review 3.  Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS).

Authors:  Marta Łukaszewicz-Zając; Barbara Mroczko; Agnieszka Słowik
Journal:  J Neural Transm (Vienna)       Date:  2014-07-22       Impact factor: 3.575
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.